BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2297752)

  • 1. Radioimmunotherapy of human colon carcinomatosis xenograft with 90Y-ZCE025 monoclonal antibody: toxicity and tumor phenotype studies.
    Esteban JM; Hyams DM; Beatty BG; Merchant B; Beatty JD
    Cancer Res; 1990 Feb; 50(3 Suppl):989s-992s. PubMed ID: 2297752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoembryonic antigen expression of resurgent human colon carcinoma after treatment with therapeutic doses of 90Y-alpha-carcinoembryonic antigen monoclonal antibody.
    Esteban JM; Kuhn JA; Felder B; Wong JY; Battifora H; Beatty JD; Wanek PM; Shively JE
    Cancer Res; 1991 Jul; 51(14):3802-6. PubMed ID: 2065334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of bone marrow transplantation in 90Y antibody therapy of colon cancer xenografts in nude mice.
    Morton BA; Beatty BG; Mison AP; Wanek PM; Beatty JD
    Cancer Res; 1990 Feb; 50(3 Suppl):1008s-1010s. PubMed ID: 2297712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunotherapy of human colonic cancer xenografts with 90Y labeled monoclonal antibodies to carcinoembryonic antigen.
    Sharkey RM; Kaltovich FA; Shih LB; Fand I; Govelitz G; Goldenberg DM
    Cancer Res; 1988 Jun; 48(11):3270-5. PubMed ID: 3365705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon enhancement of radioimmunotherapy for colon carcinoma.
    Kuhn JA; Beatty BG; Wong JY; Esteban JM; Wanek PM; Wall F; Buras RR; Williams LE; Beatty JD
    Cancer Res; 1991 May; 51(9):2335-9. PubMed ID: 1901760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical assessments of 90Y-labeled C110 anti-carcinoembryonic antigen immunotoxin: a therapeutic immunoconjugate for human colon cancer.
    Ito T; Qiu H; Collins JA; Brill AB; Johnson DK; Griffin TW
    Cancer Res; 1991 Jan; 51(1):255-60. PubMed ID: 1988087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of yttrium-90-labeled anti-carcinoembryonic antigen monoclonal antibody on the morphology and phenotype of human tumors grown as peritoneal carcinomatosis in athymic mice.
    Esteban JM; Hyams DM; Beatty BG; Wanek P; Beatty JD
    Cancer; 1989 Apr; 63(7):1343-52. PubMed ID: 2920362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of peritoneal carcinomatosis of human colon cancer xenografts with yttrium 90-labeled anti-carcinoembryonic antigen antibody ZCE025.
    Hyams DM; Esteban JM; Lollo CP; Beatty BG; Beatty JD
    Arch Surg; 1987 Nov; 122(11):1333-7. PubMed ID: 3675197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with 131I-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody.
    Gautherot E; Kraeber-Bodéré F; Daniel L; Fiche M; Rouvier E; Saï-Maurel C; Thedrez P; Chatal JF; Barbet J
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3177s-3182s. PubMed ID: 10541361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunotherapy with 153Sm-CEA monoclonal antibody in nude mice bearing human colon carcinoma: an experimental study.
    Li GP; Zhang H; Zhu CM
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Jan; 23(1):1-5. PubMed ID: 12527502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunotherapy of the GW-39 human colonic tumor xenograft with 131I-labeled murine monoclonal antibody to carcinoembryonic antigen.
    Sharkey RM; Pykett MJ; Siegel JA; Alger EA; Primus FJ; Goldenberg DM
    Cancer Res; 1987 Nov; 47(21):5672-7. PubMed ID: 3664474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous infusion chemotherapy as a radiation-enhancing agent for yttrium-90-radiolabeled monoclonal antibody therapy of a human tumor xenograft.
    Remmenga SW; Colcher D; Gansow O; Pippen CG; Raubitschek A
    Gynecol Oncol; 1994 Oct; 55(1):115-22. PubMed ID: 7959251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments.
    Buchegger F; Pfister C; Fournier K; Prevel F; Schreyer M; Carrel S; Mach JP
    J Clin Invest; 1989 May; 83(5):1449-56. PubMed ID: 2708519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local hyperthermia and SR 4233 enhance the antitumor effects of radioimmunotherapy in nude mice with human colonic adenocarcinoma xenografts.
    Wilder RB; Langmuir VK; Mendonca HL; Goris ML; Knox SJ
    Cancer Res; 1993 Jul; 53(13):3022-7. PubMed ID: 8319209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies.
    Wong JYC ; Chu DZ; Yamauchi DM; Williams LE; Liu A; Wilczynski S; Wu AM; Shively JE; Doroshow JH; Raubitschek AA
    Clin Cancer Res; 2000 Oct; 6(10):3855-63. PubMed ID: 11051230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments.
    Casey JL; Pedley RB; King DJ; Green AJ; Yarranton GT; Begent RH
    Br J Cancer; 1999 Nov; 81(6):972-80. PubMed ID: 10576653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunotherapy of carcinoma of colon with [131I]-labeled recombinant chimeric monoclonal antibodies to carcinoembryonic antigen.
    Lu QJ; Bian GX; Chen YY; Zhang M; Guo SM; Wen LQ
    Acta Pharmacol Sin; 2005 Oct; 26(10):1259-64. PubMed ID: 16174444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolongation of survival of nude mice bearing human colon cancer. Treatment with yttrium 90-labeled anti-carcinoembryonic antigen antibody.
    Hyams DM; Esteban JM; Beatty BG; Wanek PM; Beatty JD
    Arch Surg; 1989 Feb; 124(2):175-9. PubMed ID: 2916938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.